Certain Shares of Egetis Therapeutics AB (publ) are subject to a Lock-Up Agreement Ending on 13-NOV-2022. These Shares will be under lockup for 180 days starting from 17-MAY-2022 to 13-NOV-2022.

Details:
Shareholding members of the Board of Directors and management of the Company will undertake, subject to customary exceptions, not to sell shares in the Company for a period of 180 days from settlement of the Rights Issue.